ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,522,570, issued on Jan. 13, was assigned to Gilead Sciences Inc. (Foster City, Calif.).
"Toll like receptor modulator compounds" was invented by Gregory Chin (San Francisco), Richard L. Mackman (Millbrae, Calif.), Michael R. Mish (Foster City, Calif.) and Jeff Zablocki (Los Altos, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "This application relates generally to toll like receptor modulator compounds and pharmaceutical compositions which, among other things, modulate toll-like receptors (e.g. TLR8), and methods of making and using them."
The patent was filed on Sept. 27, 2023, under Application No. 18/476,141.
*For further information, includ...